Clinical Trials Directory

Trials / Completed

CompletedNCT04193085

Wearable Technology to Assess Gait Function in SMA and DMD

Wearable Technology to Assess Gait Function in Spinal Muscle Atrophy and Duchenne Muscular Dystrophy

Status
Completed
Phase
Study type
Observational
Enrollment
39 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Accepted

Summary

The purpose of this project is to devise instrumented insoles capable of accurately measuring gait at each footfall, over multiple hours in any environment. To achieve high accuracy, the investigators will develop a new learning-based calibration framework. Features will be tested in controlled lab settings 39 during a single visit in people with SMA (13), DMD (13) and healthy controls (13) and in 15 participants in real-life environments.

Detailed description

Spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are genetic disorders that often result in progressive weakness and impaired function. Results from this study will help characterize how gait is affected in SMA and DMD. This novel device can serve as a more affordable and versatile measurement instrument for neuromuscular disorders that affect gait and balance. All participants will be observed and measured while wearing the instrumented insoles in the lab and in real-life environments.

Conditions

Interventions

TypeNameDescription
OTHERObservationalObservational

Timeline

Start date
2019-11-25
Primary completion
2023-08-31
Completion
2023-08-31
First posted
2019-12-10
Last updated
2024-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04193085. Inclusion in this directory is not an endorsement.